INS and pancreatic insulinoma: According to a recent large‐scale retrospective study that used propensity‐matching analysis to compare the outcomes of EUS‐RFA and surgery for pancreatic insulinoma,21 there was no significant difference in clinical efficacy defined as the complete resolution of insulin‐related symptoms between surgery and EUS‐RFA (100% [89/89] vs. 95.5% [85/89], p = 0.160).